C4 Therapeutics, Inc. (CCCC) SEC Filings — 2024
34 SEC filings for C4 Therapeutics, Inc. (CCCC) in 2024.
Filings
- C4 Therapeutics Files 8-K — 8-K · Dec 9, 2024
- C4 Therapeutics Appoints New Chief Medical Officer — 8-K · Nov 20, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- C4 Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- C4 Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- C4 Therapeutics Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
- C4 Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- C4 Therapeutics Files 8-K/A: Director Changes & Officer Compensation — 8-K/A · Oct 16, 2024
- C4 Therapeutics Announces Board and Executive Changes — 8-K · Oct 15, 2024
- C4 Therapeutics Acquired by Biogen; New CMO Appointed — 8-K · Oct 11, 2024
- C4 Therapeutics Names New CMO, CMO Departs — 8-K · Sep 3, 2024
- C4 Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
- C4 Therapeutics Files 8-K on Security Holder Vote — 8-K · Jun 21, 2024
- C4 Therapeutics Appoints New Chief Medical Officer — 8-K · Jun 10, 2024
- C4 Therapeutics Files Q1 2024 Report — 10-Q · May 8, 2024
- C4 Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 29, 2024
- C4 Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 10, 2024
- C4 Therapeutics Appoints New Chief Medical Officer — 8-K · Mar 8, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Mar 8, 2024
- C4 Therapeutics Files 8-K: Material Agreement & Financials — 8-K · Mar 4, 2024
- C4 Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- C4 Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Wasatch Advisors Holds 14.5% Stake in C4 Therapeutics — SC 13G/A · Feb 9, 2024
- Soleus Capital Discloses Significant Stake in C4 Therapeutics — SC 13G · Feb 5, 2024
- Soleus Capital Amends C4 Therapeutics Stake as of Dec 31, 2023 — SC 13G/A · Feb 2, 2024
- Betta Investment Takes 9.9% Stake in C4 Therapeutics — SC 13G · Jan 12, 2024
- C4 Therapeutics Files Routine 8-K for Disclosure Compliance — 8-K · Jan 11, 2024
- C4 Therapeutics Reports Exit/Disposal Activities, Reg FD Disclosure — 8-K · Jan 9, 2024
- Point72 Takes 5.1% Stake in C4 Therapeutics — SC 13G · Jan 4, 2024